Neuroleptic bioequivalency: tablet versus concentrate.
Two forms of the antipsychotic neuroleptic molindone were administered to newly admitted psychotic patients. A coated tablet was administered for ten days, followed by administration of liquid concentrate in equivalent doses for four days. Plasma was analyzed by gas chromatography with electron capture for the parent compound following each dosing phase. Our data suggest that oral doses of the tablet and concentrate forms of this neuroleptic are equivalent in clinical bioavailability.
Fann
W E
WE
Moreira
A F
AF
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000097:blood; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007700:Kinetics; D008972:Molindone / Q000008:administration & dosage* / Q000097:blood; D011618:Psychotic Disorders / Q000188:drug therapy; D012996:Solutions; D013607:Tablets; D013810:Therapeutic Equivalency
D014150:Antipsychotic Agents; D007211:Indoles; D012996:Solutions; D013607:Tablets; D008972:Molindone